Market Tracker

07/27 11:26am ET

Celldex Therapeutics Inc (NASDAQ:CLDX)

4.70
BATS BZX Real-Time Price
As of 11:25am ET
 +0.04 / +0.86%
Today’s Change
2.96
Today|||52-Week Range
24.88
-70.03%
Year-to-Date
3 Biotech Stocks That Could Soar Over the Next 12 Months
Jul 19 / MotleyFool.com - Paid Partner Content
5 Things Celldex Therapeutics, Inc. Wants You to Know
Jul 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close4.66
Today’s open4.71
Day’s range4.67 - 4.76
Volume32,563
Average volume (3 months)3,073,323
Market cap$460.0M
Dividend yield--
Data as of 11:25am ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)+0.76%
Earnings growth (this year)-3.72%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.82%
P/E ratioNM
Price/Sales277.69
Price/Book1.59

Competitors

 Today’s
change
Today’s
% change
GERNGeron Corp+0.04+1.52%
--Quidel Corp+0.04+0.23%
TRIBTrinity Biotech PLC+0.10+0.79%
ALRPRBAlere Inc0.000.00%
Data as of 11:11am ET, 07/27/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$5.5M
Annual profit (last year)-$127.2M
Net profit margin-2,321.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts